What is the size of Genotyping Market?
According to 6Wresearch internal database and industry insights,
Global Genotyping Market was estimated at
USD 18 billion in 2024 and is projected to reach
USD 28 billion by 2031, growing at a
CAGR of 7.1% during the forecast period 2025â2031.
As the market is driven by the increasing prevalence of genetic disorders, advancements in genotyping technologies, and the rising demand for personalized medicine and pharmacogenomics, the market is predicted for the strong growth in the coming years.
Key Growth Drivers of the Genotyping Market
- Increasing focus on early disease detection and targeted therapies
- Rising demand for personalized and precision medicine
- Advancements in genotyping platforms such as NGS and microarrays
- Growing application in agriculture, animal breeding, and forensics
- Government initiatives supporting genomics and biotechnology research
Genotyping Market Trends
Genotyping market is experiencing growth in next-generation sequencing (NGS)-based genotyping and high-throughput screening methods. The interest is increasing in single nucleotide polymorphism (SNP) genotyping for disease risk prediction. Aside from these, the use of automated and portable genotyping systems is improving speed and accuracy in clinical and research applications. Also, the agriculture sector is increasingly using genotyping for crop improvement and animal health. Cloud-based analysis platforms are helping manage and interpret large genotypic datasets efficiently.
Emerging Developments in the Genotyping Market
Genotyping market is growing over the years which include CRISPR-based genotyping techniques for ultra-precise mutation analysis. Also, low-cost genotyping kits are being launched for point-of-care testing and remote diagnostics. As the researchers are exploring multi-gene panel testing for complex diseases like cancer and cardiovascular conditions. AI-driven analytics is being integrated to enhance interpretation accuracy. Further, the partnerships between biotech firms and healthcare providers are accelerating the development of customized genotyping panels.
Leading Companies in the Genotyping Market
- Illumina, Inc.
- Thermo Fisher Scientific
- QIAgen
- Agilent Technologies
- Bio-Rad Laboratories
- Fluidigm Corporation
- GE Healthcare
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Eurofins Genomics
How Big is the Genotyping Market : FAQs
The genotyping market was estimated at USD 18 billion in 2024 and is projected to reach USD 28 billion by 2031
The genotyping market is expected to grow at a CAGR of 7.1% from 2025 to 2031.
Major drivers include rising applications in disease diagnostics, personalized medicine, agriculture, and research.
Top players include Illumina, Thermo Fisher Scientific, QIAgen, and Bio-Rad Laboratories.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com